Healthpeak Properties, Inc. (NYSE:DOC) Stock Holdings Reduced by Securian Asset Management Inc.

Securian Asset Management Inc. lowered its position in Healthpeak Properties, Inc. (NYSE:DOC) by 3.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,592 shares of the real estate investment trust’s stock after selling 1,332 shares during the quarter. Securian Asset Management Inc.’s holdings in Healthpeak Properties were worth $762,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of DOC. Avior Wealth Management LLC purchased a new position in Healthpeak Properties in the third quarter valued at about $37,000. Groupama Asset Managment purchased a new position in Healthpeak Properties in the third quarter valued at about $37,000. Wiser Advisor Group LLC purchased a new position in Healthpeak Properties in the third quarter valued at about $42,000. Continuum Advisory LLC purchased a new position in Healthpeak Properties in the third quarter valued at about $44,000. Finally, AdvisorNet Financial Inc grew its stake in Healthpeak Properties by 34.5% in the fourth quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 563 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on DOC shares. Wells Fargo & Company decreased their price target on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Wedbush decreased their price target on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, February 14th. Scotiabank decreased their price target on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research note on Friday, February 28th. Robert W. Baird decreased their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Tuesday, February 11th. Finally, Mizuho decreased their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Thursday, December 5th. Four analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $23.92.

Healthpeak Properties Trading Up 2.1 %

Healthpeak Properties stock opened at $20.45 on Friday. The business has a 50 day moving average price of $20.21 and a two-hundred day moving average price of $21.23. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The stock has a market cap of $14.30 billion, a price-to-earnings ratio of 58.42, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a 12 month low of $17.05 and a 12 month high of $23.26.

Healthpeak Properties Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were paid a $0.305 dividend. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a dividend yield of 5.97%. The ex-dividend date of this dividend was Friday, February 14th. Healthpeak Properties’s dividend payout ratio is currently 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.